A routine blood test that costs only a few dollars may help doctors predict which teenagers with bone cancer are most likely ...

OS Therapies, Inc. OSTX on Tuesday released interim three-year overall survival data from its ongoing Phase 2b clinical evaluation. The study, known as the Metastatic Osteosarcoma Program, tests the ...

Kids with a rare bone cancer might live longer if prescribed a drug that blocks blood supply to tumors, researchers say. The drug pazopanib (Votrient) extended the lives of a small group of kids with ...

Add Yahoo as a preferred source to see more of our stories on Google. The American Cancer Society reports that the five-year relative cancer survival rate for all cancers combined hit 70% for people ...

Long-term survivors of hematopoietic cell transplantation (HCT) are at risk for loss of bone mineral density (BMD) and subsequent osteoporosis. There is a lack of clear guidelines for the screening, ...

Federal cuts to insurance and cancer research could reduce access to therapies and stifle progress when incidence is rising across many common cancers. The American Cancer Society has released its ...